The increased vascular superoxide production with endothelial dysfunction, defective CD4+ and CD8+ T-cells and the impaired complement system in diabetic patients make this group more susceptible to poor outcomes in the course of COVID-19 [24,25,26,27]. The gene discussed is CD4; the disease is endothelial dysfunction.